glp-1 cv outcome trials Beyond GLP1: modulating multiple nutrient-stimulated hormone pathways to reduce cardiovascular risk Type 2 Diabetes and Myocardial

According to some scientists, people can reduce their risk of metabolic disorders by 29 to 45 percent with more foundational dietary and lifestyle changes

Testosterone replacement therapy introduces exogenous testosterone into your body, no longer relying on your bodys testicular production

It is estimated that approximately 1 in 4 people in the world have NAFLD

Cardiac energy metabolism in heart failure

Validated mapping places the receptor in the arcuate and paraventricular nuclei of the hypothalamus, the area postrema, and the nucleus of the solitary tract in the brainstem, regions that govern hunger, satiety, and nausea

Raghavendra Tirupathi, and medical students studying under him, Shruti Vadali, Shanthi Reddy and Avinash Javajji, discuss how these medications work, who may be a good candidate, and more